Informatie:
Fout:
ID
17201
Beschrijving
Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00099944
Link
https://clinicaltrials.gov/show/NCT00099944
Trefwoorden
Versies (1)
- 31-08-16 31-08-16 -
Geüploaded op
31 augustus 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes Mellitus, Type 2 NCT00099944
Eligibility Diabetes Mellitus, Type 2 NCT00099944
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00099944
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Blood Glucose criteria Fulfill
Item
blood glucose criteria must be met
boolean
C0005802 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Sulfonylurea
Item
previously treated with a sulfonylurea for at least 3 months
boolean
C0038766 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) in the range 22-45
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Cardiac complication Serious Evidence of
Item
evidence of serious cardiovascular complications
boolean
C0161816 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
C0205404 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
Complications of Diabetes Mellitus Serious Evidence of
Item
evidence of serious diabetic complications
boolean
C0342257 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
C0205404 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
Laboratory test result abnormal
Item
laboratory value abnormalities as defined by the protocol
boolean
C0438215 (UMLS CUI [1])
Sensitivity glimepiride
Item
known sensitivity to glimepiride
boolean
C0020517 (UMLS CUI [1,1])
C0061323 (UMLS CUI [1,2])
C0061323 (UMLS CUI [1,2])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria may apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])